- Release Date: 15/05/09 08:48
- Summary: Appendix 3E
- Price Sensitive: No
- Download Document 20.96KB
- Forums
- ASX - By Stock
- LLI
- Ann: Appendix 3E
Ann: Appendix 3E
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
Add LLI (ASX) to my watchlist
(20min delay)
|
|||||
Last
14.3¢ |
Change
0.003(1.79%) |
Mkt cap ! $12.98M |
Open | High | Low | Value | Volume |
13.5¢ | 14.3¢ | 13.5¢ | $24.54K | 178.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8138 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 34340 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8138 | 0.140 |
1 | 14818 | 0.135 |
3 | 23252 | 0.130 |
1 | 50000 | 0.120 |
1 | 50000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 34340 | 2 |
0.150 | 161546 | 1 |
0.155 | 13000 | 1 |
0.160 | 35210 | 2 |
0.165 | 18490 | 1 |
Last trade - 15.02pm 10/10/2024 (20 minute delay) ? |
Featured News
LLI (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online